EIR AstraZeneca Pharmaceuticals LP Aug 2019

Aimee Cunningham FDA$595.00 - Available Now

FDA investigators audited the AstraZeneca Pharmaceuticals LP - Frederick, MD, United States facility and issued inspectional observation (via FDA 483) on 26 Aug 2019.

Product details

  • Category:
  • Inspection end: 26 Aug 2019
  • Location: Frederick, United States
  • FEI: 3002617771
Add To Cart